Stockholders approve 6M extra shares for equity plan and 1.2M for ESPP

Envoy Medical, Inc.

6,000,000 additional shares authorized under Amended and Restated 2023 Equity Incentive Plan (effective May 12, 2026).
1,200,000 additional shares authorized under 2023 Employee Stock Purchase Plan.
Stockholders re-elected directors Brent T. Lucas and Susan J. Kantor to Class III terms until 2029.
Ratified EisnerAmper LLP as independent auditor for fiscal year ending December 31, 2026.
Approved advisory executive compensation and issuance of warrants per Nasdaq Rule 5635(d).

Key facts

Extracted from this filing and checked against the source text.

Shareholder Votes SEC 8-K Item 5.07 confidence 0.95

Envoy Medical, Inc. shareholders approved Election of two Class III director nominees, Brent T. Lucas and Susan J. Kantor at the 2026-05-18 meeting.

Proposal: director election
Outcome: passed
Meeting: 2026-05-18

Exact text from the filing

1. The Company’s stockholders elected two Class III director nominees, Brent T. Lucas and Susan J. Kantor, to the Company’s Board of Directors to hold office until the earlier of the 2029 annual meeting of stockholders, the election of such director’s successor, or such director’s death, resignation or removal;

View on SEC.gov

Shareholder Votes SEC 8-K Item 5.07 confidence 0.95

Envoy Medical, Inc. shareholders approved Amendment to the Employee Stock Purchase Plan to authorize an additional 1,200,000 shares of Common Stock for issuance under such plan at the 2026-05-18 meeting.

Proposal: equity plan
Outcome: passed
Meeting: 2026-05-18

Exact text from the filing

5. Stockholders approved an amendment to the Employee Stock Purchase Plan to authorize an additional 1,200,000 shares of Common Stock for issuance under such plan;

View on SEC.gov

Shareholder Votes SEC 8-K Item 5.07 confidence 0.95

Envoy Medical, Inc. shareholders approved Amendment to the Equity Incentive Plan to authorize an additional 6,000,000 shares of Common Stock for issuance under such plan at the 2026-05-18 meeting.

Proposal: equity plan
Outcome: passed
Meeting: 2026-05-18

Exact text from the filing

4. Stockholders approved an amendment to the Equity Incentive Plan to authorize an additional 6,000,000 shares of Common Stock for issuance under such plan;

View on SEC.gov

Shareholder Votes SEC 8-K Item 5.07 confidence 0.95

Envoy Medical, Inc. shareholders approved Approval, on a non-binding and advisory basis, of the compensation of the Company's named executive officers at the 2026-05-18 meeting.

Proposal: say on pay
Outcome: passed
Meeting: 2026-05-18

Exact text from the filing

3. Stockholders approved, on a non-binding and advisory basis, the compensation of the Company’s named executive officers;

View on SEC.gov

Shareholder Votes SEC 8-K Item 5.07 confidence 0.9

Envoy Medical, Inc. shareholders approved Approval for the purposes of complying with Nasdaq Listing Rule 5635(d) of the issuance of warrants to purchase shares of Common Stock and the issuance of Class A Common Stock underlying such warrants issued in a transaction completed on February 12, 2026 at the 2026-05-18 meeting.

Outcome: passed
Meeting: 2026-05-18

Exact text from the filing

6. Stockholders approved, for the purposes of complying with Nasdaq Listing Rule 5635(d), the issuance of warrants to purchase shares of the Common Stock, and the issuance of Class A Common Stock underlying such warrants, that were issued in a transaction that was completed on February 12, 2026.

View on SEC.gov

Shareholder Votes SEC 8-K Item 5.07 confidence 0.95

Envoy Medical, Inc. shareholders approved Ratification of the appointment of EisnerAmper, LLP as the independent registered public accounting firm for the fiscal year ending December 31, 2026 at the 2026-05-18 meeting.

Proposal: auditor ratification
Outcome: passed
Meeting: 2026-05-18

Exact text from the filing

2. Stockholders ratified the appointment of EisnerAmper, LLP as the Company’s independent registered public accounting firm for the fiscal year ending December 31, 2026;

View on SEC.gov

63 shareholder votes filed in the last 30 days. Browse all shareholder votes →

Envoy Medical, Inc. filing history →

Source: SEC EDGAR

accession 0001213900-26-058429

view filing index on sec.gov

view primary document

Machine-readable: JSON · Markdown · Plain text

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.